Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.-Reference-Cited by-同舟云学术

Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.

Published:1985-02-01 Issue:2 Volume:26 Page:114-119
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Neuberger J,Christensen E,Portmann B,Caballeria J,Rodes J,Ranek L,Tygstrup N,Williams R

Publisher

BMJ

Subject

Gastroenterology

Reference17 articles.

1. Effect of steroid therapy on the chemical and laboratory features of primary biliary cirrhosis;Carman, C.T.; Giansiracusa, J.E.;Gastroenterology,1955

2. The late results of long-term treatment of primary biliary cirrhosis by corticosteroids;Howat, H.T.; Ralston, A.J.; Varley, H.; Wilson, J.A.C.;Rev Int Hepatol,1966

3. Azathioprine in primary biliary cirrhosis. A preliminary report of;Crowe, J.; Christensen, E.; Smith, M.

4. d-penicillamine treatment improves survival in patients with primary biliary cirrhosis;Epstein, O.; Jain, S.; Lee, R.G.;Lancet,1981

5. Reduction of immune complexes and immunoglobulins in primary biliary cirrhosis;N Engl J Med,1979

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variable selection using inverse probability of censoring weighting;Statistical Methods in Medical Research;2023-09-07

2. Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?;Hepatology;2022-03-10

3. Primary Biliary Cholangitis;Clinical Cases in Hepatology;2021-10-26

4. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases;Hepatology;2018-11-06

5. Improving prognosis in primary biliary cholangitis – Therapeutic options and strategy;Best Practice & Research Clinical Gastroenterology;2018-06